Riskpilot← Back to searchSign inGet full accessSYNSENTERET FLORØ AS
ASActiveOrg 855490722Hans Blomgate 39, 6905 FlorøRetail sale of medical and orthopaedic goods · NACE 4774Est. 19905 employees
Revenue 2024
NOK 6,1M
+7% vs 2023
EBITDA margin
19.3%
+44% vs 2023
Equity ratio
43.3%
Financial strength
Net profit 2024
NOK 934K
+48% vs 2023
| Revenue | NOK 6,1M | +7% |
| EBITDA | NOK 1,2M | +44% |
| Net profit | NOK 934K | +48% |
| Total assets | NOK 2,6M | +16% |
| Equity | NOK 1,1M | +27% |
| Employees | 5 | — |
Legal name
SYNSENTERET FLORØ AS
Org number
855490722
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
1. januar 1990
Share capital
NOK 100 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Salg og optikervirksomhet og hva dermed står forbindelse, herund ved innskudd av kapital, eventuelt ved aksjetegning å delta i andre virksomheter.
Address
Hans Blomgate 39, 6905 Florø
Phone
+4757820313
Email
synsent@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 763 | 5 506 | 5 543 | 5 680 | 6 075 |
| Staff expenses | −1 740 | −1 974 | −1 982 | −2 206 | −2 086 |
| EBITDA | 1 632 | 1 055 | 957 | 814 | 1 171 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 632 | 1 055 | 957 | 814 | 1 171 |
| Net financials | 10 | 15 | 25 | 22 | 35 |
| Profit before tax | 1 641 | 1 070 | 982 | 836 | 1 206 |
| Tax | 405 | 217 | 230 | 205 | 272 |
| Net profit | 1 237 | 853 | 753 | 632 | 934 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 281 | 4 693 | 5 561 | 2 199 | 2 559 |
| Equity | 3 043 | 2 896 | 2 572 | 875 | 1 108 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 239 | 1 797 | 2 989 | 1 324 | 1 450 |
| Total debt | 2 239 | 1 797 | 2 989 | 1 324 | 1 450 |
EBITDA margin
19.3%
This company
15.8%
Market median
+22% vs market
20202024
Equity ratio
43.3%
This company
38.2%
Market median
+13% vs market
20202024
Return on equity
84.3%
This company
18.4%
Market median
+358% vs market
20202024
Net profit margin
15.4%
This company
8.1%
Market median
+90% vs market
20202024
Asset turnover
2.37×
This company
1.12×
Market median
+112% vs market
20202024
Debt / equity
1.31×
This company
0.62×
Market median
-111% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
PE Deputy Member | Deputy Member | 1990 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 | |
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Morymo Holding As
SYNSENTERET FLORØ AS Board members of SYNSENTERET FLORØ AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Evensen | Deputy Member | 0 companies |
| Mone Linn Rye Moen | Chairman | 0 companies |
| Hildegunn Hovland | Board of Directors | 0 companies |